Dr. James Jacobson Peairs, MD

Dr. Peairs practices at Surgery Center of California in Chula Vista, California.

Dr. Peairs' NPI, 1609135623, was assigned on May 10, 2012. Dr. Peairs graduated from Boston University School Of Medicine in 2012. Dr. Peairs' Iowa license number on file is MD-43387.

Dr. Peairs' primary practice is Surgery Center of California, at 835 3rd Avenue, Suite A, Chula Vista, CA 91911. The practice phone is (619) 425-4209.

Dr. Peairs' primary practice is Surgery Center of California in Chula Vista, California. Dmand AI also links Dr. Peairs to 1 medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Peairs practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Peairs' primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Peairs is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Peairs' licenses on file in 3 states: Iowa, California and District of Columbia.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Peairs treats.

CMS data shows 9,176 Medicare services from Dr. Peairs across 20 procedure codes in 2024, for 1,698 Medicare patients. Medicare paid $837,362 for them.

CMS counts 1,698 Medicare patients who saw Dr. Peairs in 2024. The largest group is 65 to 74, with 787 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 64% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Peairs' median patient age at 67, with 60% women.

In 2024, Dr. Peairs wrote 6,293 Medicare Part D claims for 1,178 patients. 67% of them were for generic drugs. CMS names the drug for 6,237 of them, across 29 drugs with 11 or more claims each, at $463,696 in total drug cost. In 2023, CMS named 5,249 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Peairs for performance year 2024, reported as part of a group. Dr. Peairs accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 79 procedures of cataract surgery by Dr. Peairs, more than 71% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Peairs. The most frequent topics are Apoptosis, Cell Survival and Pigment Epithelium of Eye. Dr. Peairs has published most often in Invest Ophthalmol Vis Sci. Dr. Peairs' most frequent co-authors are Nanfei Zhang, MD and Jessica L. Wiser, MD.

CMS Open Payments shows 108 general payments to Dr. Peairs from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 88% of the total. Alcon Laboratories Inc paid the most, $2,193.

Dr. Peairs graduated from Boston University School Of Medicine in 2012. Dr. Peairs is a member of ASRS.

Dr. Peairs is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.